Nuclear Medicine Radioisotopes Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Nuclear Medicine Radioisotopes market is expected to grow at a CAGR of 3.4% during the forecast period.
The global Nuclear Medicine Radioisotopes market is estimated to be about 3642.8 million US dollars in 2020.
The global Nuclear Medicine Radioisotopes market is estimated to reach 4167.9 million USD by 2026.
The global Nuclear Medicine Radioisotopes market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Nuclear Medicine Radioisotopes market will be able to gain an advantage as they use reports as a powerful resource.
Nuclear Medicine Radioisotopes markets by category
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Nuclear Medicine Radioisotopes Market by Application (Percentage of Demand)
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Who are the leading companies in Nuclear Medicine Radioisotopes
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Nuclear Medicine Radioisotopes markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Nuclear Medicine Radioisotopes.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Nuclear Medicine Radioisotopes Revenue and Growth Forecast 2014-2026
2.2 Global Nuclear Medicine Radioisotopes Market Size and Growth Forecast 2014-2026
2.3 Global Nuclear Medicine Radioisotopes Revenue by Region 2014-2026
2.4 Nuclear Medicine Radioisotopes Market Share by Major Regions 2014-2021
2.5 Nuclear Medicine Radioisotopes Gross Margin in Different Region 2014-2021
2.6 Global Nuclear Medicine Radioisotopes Market History Price and Forecast 2014-2026
2.7 Global Nuclear Medicine Radioisotopes Sales Market Share by Top Companies 2014-2021
3 Global Nuclear Medicine Radioisotopes Market by Type
3.1 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Nuclear Medicine Radioisotopes Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Nuclear Medicine Radioisotopes Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 Thallium-201 (Tl-201)
3.4.2 Iodine (I-123)
3.4.3 Fluorine-18
3.4.4 Rubidium-82 (Rb-82)
3.4.5 Other
4 Global Nuclear Medicine Radioisotopes Market by Application
4.1 Global Nuclear Medicine Radioisotopes Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Nuclear Medicine Radioisotopes Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Tumor
4.3.2 Heart Disease
4.3.3 Lymphoma
4.3.4 Thyroid Gland
4.3.5 Other
5 North America Nuclear Medicine Radioisotopes Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Nuclear Medicine Radioisotopes Value ($) from 2014-2021
5.2 North America Nuclear Medicine Radioisotopes Market Size from 2014-2021
5.3 North America Nuclear Medicine Radioisotopes Price Change from 2014-2021
5.4 North America Nuclear Medicine Radioisotopes Import and Export from 2014-2021
5.5 North America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2020
6 Europe Nuclear Medicine Radioisotopes Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Nuclear Medicine Radioisotopes Value ($) from 2014-2021
6.2 Europe Nuclear Medicine Radioisotopes Market Size from 2014-2021
6.3 Europe Nuclear Medicine Radioisotopes Price Change from 2014-2021
6.4 Europe Nuclear Medicine Radioisotopes Import and Export from 2014-2021
6.5 Europe Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Nuclear Medicine Radioisotopes Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Nuclear Medicine Radioisotopes Value ($) from 2014-2021
7.2 Asia-Pacific Nuclear Medicine Radioisotopes Market Size from 2014-2021
7.3 Asia-Pacific Nuclear Medicine Radioisotopes Price Change from 2014-2021
7.4 Asia-Pacific Nuclear Medicine Radioisotopes Import and Export from 2014-2021
7.5 Asia-Pacific Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2020
8 Latin America Nuclear Medicine Radioisotopes Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Nuclear Medicine Radioisotopes Value ($) from 2014-2021
8.2 Latin America Nuclear Medicine Radioisotopes Market Size from 2014-2021
8.3 Latin America Nuclear Medicine Radioisotopes Price Change from 2014-2021
8.4 Latin America Nuclear Medicine Radioisotopes Import and Export from 2014-2021
8.5 Latin America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Nuclear Medicine Radioisotopes Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Nuclear Medicine Radioisotopes Value ($) from 2014-2021
9.2 Middle East & Africa Nuclear Medicine Radioisotopes Market Size from 2014-2021
9.3 Middle East & Africa Nuclear Medicine Radioisotopes Price Change from 2014-2021
9.4 Middle East & Africa Nuclear Medicine Radioisotopes Import and Export from 2014-2021
9.5 Middle East & Africa Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Nuclear Medicine Radioisotopes Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Nuclear Medicine Radioisotopes Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Agfa-Gevaert Group
10.1.1 Agfa-Gevaert Group Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Agfa-Gevaert Group Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Agfa-Gevaert Group Value and Growth Change from 2014-2021
10.1.4 Agfa-Gevaert Group Price Change from 2014-2021
10.1.5 Agfa-Gevaert Group Product Offered
10.2 Braco
10.2.1 Braco Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 Braco Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 Braco Value and Growth Change from 2014-2021
10.2.4 Braco Price Change from 2014-2021
10.2.5 Braco Product Offered
10.3 Cardiarc
10.3.1 Cardiarc Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 Cardiarc Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 Cardiarc Value and Growth Change from 2014-2021
10.3.4 Cardiarc Price Change from 2014-2021
10.3.5 Cardiarc Product Offered
10.4 Cardinal Health
10.4.1 Cardinal Health Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Cardinal Health Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Cardinal Health Value and Growth Change from 2014-2021
10.4.4 Cardinal Health Price Change from 2014-2021
10.4.5 Cardinal Health Product Offered
10.5 CMR Naviscan (Gamma Medica Inc.)
10.5.1 CMR Naviscan (Gamma Medica Inc.) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 CMR Naviscan (Gamma Medica Inc.) Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 CMR Naviscan (Gamma Medica Inc.) Value and Growth Change from 2014-2021
10.5.4 CMR Naviscan (Gamma Medica Inc.) Price Change from 2014-2021
10.5.5 CMR Naviscan (Gamma Medica Inc.) Product Offered
10.6 Curium
10.6.1 Curium Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 Curium Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 Curium Value and Growth Change from 2014-2021
10.6.4 Curium Price Change from 2014-2021
10.6.5 Curium Product Offered
10.7 Digirad
10.7.1 Digirad Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Digirad Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Digirad Value and Growth Change from 2014-2021
10.7.4 Digirad Price Change from 2014-2021
10.7.5 Digirad Product Offered
10.8 GE Healthcare
10.8.1 GE Healthcare Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 GE Healthcare Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 GE Healthcare Value and Growth Change from 2014-2021
10.8.4 GE Healthcare Price Change from 2014-2021
10.8.5 GE Healthcare Product Offered
10.9 Nordion (Canada)
10.9.1 Nordion (Canada) Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Nordion (Canada) Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Nordion (Canada) Value and Growth Change from 2014-2021
10.9.4 Nordion (Canada) Price Change from 2014-2021
10.9.5 Nordion (Canada) Product Offered
10.10 NTP Radioisotopes SOC
10.10.1 NTP Radioisotopes SOC Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 NTP Radioisotopes SOC Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 NTP Radioisotopes SOC Value and Growth Change from 2014-2021
10.10.4 NTP Radioisotopes SOC Price Change from 2014-2021
10.10.5 NTP Radioisotopes SOC Product Offered
10.11 Positron
10.11.1 Positron Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 Positron Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 Positron Value and Growth Change from 2014-2021
10.11.4 Positron Price Change from 2014-2021
10.11.5 Positron Product Offered
10.12 Segami
10.12.1 Segami Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Segami Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Segami Value and Growth Change from 2014-2021
10.12.4 Segami Price Change from 2014-2021
10.12.5 Segami Product Offered
10.13 Siemens Healthcare
10.13.1 Siemens Healthcare Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 Siemens Healthcare Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 Siemens Healthcare Value and Growth Change from 2014-2021
10.13.4 Siemens Healthcare Price Change from 2014-2021
10.13.5 Siemens Healthcare Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Nuclear Medicine Radioisotopes by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Nuclear Medicine Radioisotopes Market from 2020-2026
12.1 Future Forecast of Global Nuclear Medicine Radioisotopes Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Nuclear Medicine Radioisotopes Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Nuclear Medicine Radioisotopes Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Nuclear Medicine Radioisotopes Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|